Key Functional Areas
Through systematic data collection, risk identification, and regulatory compliance, this process strengthens trust in healthcare and fosters innovation
All safety data from internal systems, external partners, regulatory sources, social media, and scientific literature is consolidated into a single intelligent intake layer using NLP-based OCR and multimodal ingestion, enabling structured capture and eliminating duplication.
Cases are automatically classified using machine learning models trained on severity, case type, and regulatory relevance, ensuring critical cases receive immediate attention. AI agents have demonstrated up to 40% reduction in turnaround times in production deployments.
Deep learning models continuously track patterns in safety data across EHR systems, literature, and adverse event databases to detect emerging risks and anomalies earlier than traditional methods. AI-powered signal systems have accelerated analyst review and enabled earlier detection of patient safety issues.
Automated NLP models screen scientific literature in real time, filtering irrelevant content and surfacing relevant adverse drug reaction (ADR) reports. Implementations have shown over 80% reduction in human review volume while retaining 100% sensitivity for confirmed safety papers.
AI-driven predictive models assess individual patient risk for ADRs based on demographics, comorbidities, medication history, and biomarker data, enabling precision medicine and proactive safety management.
Each case progresses through intelligent, rule-based and ML-assisted workflows with defined ownership, timelines, and escalation paths, ensuring consistency and accountability.
Generative AI supports the drafting of regulatory submissions aligned with global standards, reducing manual effort and improving submission accuracy.
Previous
Next
Operational Impact
Pharma teams benefit from faster case processing, dramatically reduced manual intervention, and higher data accuracy. AI systems have demonstrated up to 30% improvement in data accuracy in pharmacovigilance deployments. Compliance teams gain real-time, AI-backed visibility into case status and reporting readiness, enabling proactive risk management and stronger regulatory alignment.